We are mainly addressing diseases related to CSF on the rise in the world’s aging populations. Likvor AB’s products are CE marked and sold to hospitals and clinics with a focus on neurology and neurosurgery. Likvor AB is located in Umeå, in northern Sweden, and has Swedish owners. We are also committed to explore and develop new methods and devices in close collaboration with researchers at Umeå University and Umeå University Hospital. Likvor AB and the CELDA System can be used for several diseases and is unique when it comes to accuracy, efficiency and usability.Contact me to learn more. Likvor CELDA System includes several examination protocols allowing for automated infusion testing and making the results independent of patient and investigator performance. Likvor CELDA™️ System sets a new standard for diagnostics of disease linked to disturbances in the cerebrospinal fluid system such as iNPH and iIH. The Likvor CELDA™ Instrument is not only unique as the first commercial instrument for better diagnostics of iNPH but it is also a superior instrument for testing implanted shunt devices.
Umeå, Sweden
Founded in 2007
1-10 Employees
Working industry
Medical
Type of company
Manufacturer
Ownership structure
Privately Held
Locations
1 Headquarter
Number of products
2 Products
Specialised areas
Health Care, Pharmaceutical
Likvor offers a wide range of products and services
Product
Genom att kombinera de båda bolagens tekniker och metoder kan specialister inom neurologi och neurokirurgi få bättre beslutsunderlag. - Likvor AB
Go to product >
Product
Likvor is partnering with GERAS Solutions to drive awareness and improve objective diagnostics of cognitive disorders - Likvor AB
Go to product >
An estimation about the ESG values based on digital data and signals. Important: The ESG scores are only based on information about the country, not the actual company itself
Country:
Sweden
Overall risk estimation:
Very low
The ESG Data of countries are based on public sources
Environment
A
Grade (A-E)
View details
Social
B
Grade (A-E)
View details
Governance
A
Grade (A-E)
View details
Get insights into the use cases of Likvor
Use case
Pengar till forskningsprojekt i Umeå om ”hjärnans tvättmaskin”, det glymfatiska systemet - Likvor AB
Projektet Glymfatiska systemet - en faktor vid demensutveckling handlar om att komma vidare med metoder för att undersöka det glymfatiska systemet på människor. Förhoppningsvis ska detta ge vården nya verktyg för diagnos och behandling, säger Anders Eklund, professor vid Umeå universitet och projektledare. Forskargruppen är sedan tidigare världsledande inom forskning på hydrocefalus…
Likvor operates in 1 country around the world
Get an overview of the locations of Likvor
Location
Country
State
City
Headquarter
Sweden
Västerbotten County
Umeå
Some frequent questions that have been asked about Likvor
Where is Likvor located?
The company headquarter of Likvor is located in Umeå, Västerbotten County, Sweden. It's worth noting, that the company may have more locations
How many employees does Likvor approximately have?
As of the latest available information Likvor has around 1-10 employees worldwide.
When was Likvor founded?
Likvor was founded in 2007
In which industries does Likvor mainly work?
The company Likvor has it's main focus in the industries of Medical
Check out some interesting alternative companies to Likvor
Cellavision Ab Ord
Lund, Sweden
101-250 Employees
1994
CellaVision offers the latest innovations for analyzers, instruments, reagents, and software used in hematology laboratories. Our mission: To advance laboratory workflow and diagnostic certainty through intelligent microscopy. Our goal is to provide value to patients, customers, distributors, and owners by incorporating smart solutions into everything we do. CellaVision is a world-leading provider of digital hematology microscopy solutions, covering analyzers, instruments, reagents, and software. CellaVision has over 230 employees, with global Headquarters in Lund, Sweden. Welcome to the first CellaVision Global Test of the year! We are constructing a new building on the site of our reagent manufacturing facility in Martillac (France) and investing in new production equipment. Our long-term success is a result of our commitment to innovation.
atHeart Medical
Baar, Switzerland
11-50 Employees
2021
We are problem solvers developing meaningful solutions for unmet clinical needs. Our company was founded by the Olle Larsson Holding AG (OLH), a Swiss corporate group with a diverse portfolio of companies in medical devices, among other sectors. We work from “the heart” with a primary focus on our patients.
LOMINA A.G.
Prague, Czechia
11-50 Employees
2007
Lomina Group has been established in 2007 in Switzerland as an A.G. LOMINA AG is also registered as Organizational Unit in the Czech Republic. We are constantly delivering required business results, meeting deadlines and productivity and performance standards. We manufacture laboratory in vitro diagnostic devices (IVD), which react to a number of diseases, including infections, tumours, cardiac disease and others. The Lomina Mobile Laboratory (LOMINA LAB) is a diagnostic kit in the form of a diagnostic IVD case, intended for easy and fast collection and assessment of diagnostic assays, including biochemical values. All LOMINA products are registered at Czech RZPRO and European EUDAMED database. All LOMINA products are registered In accordance with Directive 98/79/EC of the European Parliament and of the Council and according to:. Our two main divisions are LOMINA AG and LOMINA Superbio a.s., during which time LOMINA Superbio focuses on development and manufacture of in vitro diagnostic medical devices (IVD).
LVIS
Seoul, South Korea
1-10 Employees
2015
LVIS is a technology company developing products to revolutionize neuro care through rapid and accurate identification of complex neural network patterns. NeuroMatch® is the LVIS software as a medical device product line which will exponentially increase neurological patient throughput by enabling AI to interpret data in a matter of seconds (digital) rather than hours (analog). The shortage of neurologists (1 per 23,259 people) is a “grave threat”*** as the supply has remained relatively constant. In addition to the provider shortage, sub-optimal workflows and ineffective therapeutic options further constrain patient throughput.
ClearSky Medical Diagnostics
Markham, Canada
- Employees
-
The company is a spinout company from the University of York’s Department of Electronics, established by co-founder and director Dr Stephen Smith and academics over the past ten years. The result is a portfolio of non-invasive devices that provide a safe, quick and objective assessment of patients’ symptoms. LID-Monitor offers a safe, simple and unobtrusive way of monitoring dyskinesia in the home.
CSF-Dynamics
Kongens Lyngby, Denmark
1-10 Employees
1996
We are convinced that this method has a future in the standard of care and will move forwards to plan a larger study as soon as possible. After several years of research and technological development at CSF-Dynamics we can now present the results of the pilot study on our novel CSF-shunting device.